Effect of Timolol on Aqueous Humor Outflow Facility in Healthy Human Eyes

Overview

Journal Am J Ophthalmol

Specialty Ophthalmology

Date 2019 Feb 23

PMID 30794789

Citations 9

Authors

Arash Kazemi

Jay W McLaren

Matthew G J Trese

Carol B Toris

Vikas Gulati

Shan Fan

David M Reed

Tyler Kristoff

Jesse Gilbert

Sayoko E Moroi

Arthur J Sit

Affiliations

Soon will be listed here.

Abstract

Purpose: Hyposecretion of aqueous humor has been postulated to adversely affect the health of the trabecular meshwork and outflow resistance. However, the effect of medications that reduce aqueous humor production on outflow facility in living human eyes is unclear. This study evaluated the effect of timolol, an aqueous humor flow suppressant, on outflow facility in healthy eyes.

Design: Prospective, before-and-after study.

Methods: In a multicenter study, 113 healthy participants over 40 years of age were included. Intraocular pressure (IOP) was measured with the participant in the sitting position by using a pneumatonometer. The outflow facility was measured with the participant in the supine position by 2-minute pneumatonography. After participants self-administered drops of timolol 0.5% for 1 week, twice daily in each eye, both measurements were repeated.

Results: Mean IOP decreased from 15.1 ± 3.0 mm Hg at baseline to 12.4 ± 2.4 mm Hg (P < 0.001) after 1 week of timolol use. Mean outflow facility decreased from 0.23 ± 0.08 μL/min/mm Hg at baseline to 0.18 ± 0.08 μL/min/mm Hg (P < 0.001) after timolol. The change in outflow facility was negatively correlated with baseline outflow facility (r = -0.51; P < 0.001).

Conclusions: Timolol reduces outflow facility in healthy human eyes, and this effect is greater in eyes with higher baseline outflow facility. This phenomenon may be related to reduced aqueous humor flow, but the precise mechanism remains to be determined.

Citing Articles

Lipidomic Analysis Reveals Drug-Induced Lipoxins in Glaucoma Treatment.

Mathew D, Maurya S, Ho J, Livne-Bar I, Chan D, Buys Y bioRxiv. 2025; .

PMID: 39975338 PMC: 11838192. DOI: 10.1101/2025.01.24.634771.

Effect of a fixed combination of ripasudil and brimonidine on aqueous humor dynamics in mice.

Yamagishi-Kimura R, Honjo M, Aihara M Sci Rep. 2024; 14(1):7861.

PMID: 38570526 PMC: 10991514. DOI: 10.1038/s41598-024-58212-6.

Efficacy of Morning Versus Evening Latanoprost/Timolol Fixed Combination for Open-Angle Glaucoma and Ocular Hypertension: A Randomized Clinical Trial.

Feng H, Han D, Lu W, Tang G, Zhang H, Fan S Transl Vis Sci Technol. 2024; 13(1):21.

PMID: 38285464 PMC: 10829799. DOI: 10.1167/tvst.13.1.21.

Connective tissue growth factor: Role in trabecular meshwork remodeling and intraocular pressure lowering.

Hassan M, Razali N, Bakar A, Abu Hanipah N, Agarwal R Exp Biol Med (Maywood). 2023; 248(16):1425-1436.

PMID: 37873757 PMC: 10657592. DOI: 10.1177/15353702231199466.

RNA-seq analysis of human trabecular endothelial cells after treatment with timolol maleate.

Palchunova K, Kaji Y, Fujita A, Oshika T Jpn J Ophthalmol. 2023; 67(4):440-447.

PMID: 37314597 DOI: 10.1007/s10384-023-00998-5.

References

Dailey R, Brubaker R, Bourne W . The effects of timolol maleate and acetazolamide on the rate of aqueous formation in normal human subjects. Am J Ophthalmol. 1982; 93(2):232-7. DOI: 10.1016/0002-9394(82)90419-6. View

Brubaker R . Flow of aqueous humor in humans [The Friedenwald Lecture]. Invest Ophthalmol Vis Sci. 1991; 32(13):3145-66. View

Zimmerman T, Kass M, Yablonski M, Becker B . Timolol maleate: efficacy and safety. Arch Ophthalmol. 1979; 97(4):656-8. DOI: 10.1001/archopht.1979.01020010312004. View

Croft M, Oyen M, Gange S, Fisher M, Kaufman P . Aging effects on accommodation and outflow facility responses to pilocarpine in humans. Arch Ophthalmol. 1996; 114(5):586-92. DOI: 10.1001/archopht.1996.01100130578015. View

Becker B . The decline in aqueous secretion and outflow facility with age. Am J Ophthalmol. 1958; 46(5 Part 1):731-6. DOI: 10.1016/0002-9394(58)91272-8. View

Zimmerman T, Kaufman H . Timolol, dose response and duration of action. Arch Ophthalmol. 1977; 95(4):605-7. DOI: 10.1001/archopht.1977.04450040071009. View

Sit A, Nau C, McLaren J, Johnson D, Hodge D . Circadian variation of aqueous dynamics in young healthy adults. Invest Ophthalmol Vis Sci. 2008; 49(4):1473-9. PMC: 2747618. DOI: 10.1167/iovs.07-1139. View

Katz I, Hubbard W, Getson A, Gould A . Intraocular pressure decrease in normal volunteers following timolol ophthalmic solution. Invest Ophthalmol. 1976; 15(6):489-92. View

Boger 3rd W, Puliafito C, Steinert R, Langston D . Long-term experience with timolol ophthalmic solution in patients with open-angle glaucoma. Ophthalmology. 1978; 85(3):259-67. DOI: 10.1016/s0161-6420(78)35673-6. View

10.

Toris C, Yablonski M, Wang Y, Camras C . Aqueous humor dynamics in the aging human eye. Am J Ophthalmol. 1999; 127(4):407-12. DOI: 10.1016/s0002-9394(98)00436-x. View

11.

Boger 3rd W, Steinert R, Thomas J . Timolol in the therapy of "ocular hypertension". Surv Ophthalmol. 1980; 25(3):195-202. DOI: 10.1016/0039-6257(80)90098-3. View

12.

WEEKERS R, WATILLON M, DE RUDDER M . Experimental and clinical investigations into the resistance to outflow of aqueous humour in normal subjects. Br J Ophthalmol. 1956; 40(4):225-33. PMC: 509469. DOI: 10.1136/bjo.40.4.225. View

13.

Boger 3rd W . Timolol: short term "escape" and long term "drift". Ann Ophthalmol. 1979; 11(8):1239-42. View

14.

Gabelt B, Crawford K, Kaufman P . Outflow facility and its response to pilocarpine decline in aging rhesus monkeys. Arch Ophthalmol. 1991; 109(6):879-82. DOI: 10.1001/archopht.1991.01080060143044. View

15.

Gabelt B, Kaufman P . Changes in aqueous humor dynamics with age and glaucoma. Prog Retin Eye Res. 2005; 24(5):612-37. DOI: 10.1016/j.preteyeres.2004.10.003. View

16.

Camras C . Comparison of latanoprost and timolol in patients with ocular hypertension and glaucoma: a six-month masked, multicenter trial in the United States. The United States Latanoprost Study Group. Ophthalmology. 1996; 103(1):138-47. DOI: 10.1016/s0161-6420(96)30749-5. View

17.

Alexander D, Berson F, Epstein D . A clinical trial of timolol and epinephrine in the treatment of primary open-angle glaucoma. Ophthalmology. 1988; 95(2):247-51. DOI: 10.1016/s0161-6420(88)33205-7. View

18.

Larsson L . Aqueous humor flow in normal human eyes treated with brimonidine and timolol, alone and in combination. Arch Ophthalmol. 2001; 119(4):492-5. DOI: 10.1001/archopht.119.4.492. View

19.

. Does hyposecretion of aqueous humor damage the trabecular meshwork?. J Glaucoma. 2009; 4(5):303-5. View

20.

Boger 3rd W, Steinert R, Puliafito C . Clinical trial comparing timolol ophthalmic solution to pilocarpine in open-angle glaucoma. Am J Ophthalmol. 1978; 86(1):8-18. DOI: 10.1016/0002-9394(78)90006-5. View